Incidence of hyperlipidemia in kidney transplant patients treated with a combination regimen of sirolimus(Rapa)-cyclosporine(CsA)-prednisone(Pred)

被引：3
|
作者：
Suri, A
Kahan, BD
机构：
[1] Univ Texas, Sch Med, Div Immunol & Organ Transplantat, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Div Nephrol, Houston, TX 77030 USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00671
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
646
引用
下载
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [41] Comparison of tacrolimus(TAC) and sirolimus(SLR) versus cyclosporine(CSA) and SLR in kidney transplant recipients maintained on steroid free immunosuppression.
    Saeed, MI
    Kumar, MSA
    Heifets, M
    Sierka, D
    Xiao, SG
    Moritz, MJ
    Parikh, MH
    Fyfe, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 218 - 218
  • [42] A PROSPECTIVE RANDOMIZED TRIAL OF PREDNISONE VERSUS NO PREDNISONE MAINTENANCE THERAPY IN CYCLOSPORINE-TREATED AND AZATHIOPRINE-TREATED RENAL-TRANSPLANT PATIENTS
    SCHULAK, JA
    MAYES, JT
    MORITZ, CE
    HRICIK, DE
    TRANSPLANTATION, 1990, 49 (02) : 327 - 332
  • [43] Comparing a corticosteroid and calcineurin-free immunosuppression protocol to a conventional sirolimus, cyclosporine and prednisone-based regimen for pancreas-kidney transplantation
    Knight, Richard J.
    Podder, Hemangshu
    Lawless, Amy
    Kerman, Ronald H.
    Katz, Stephen M.
    Van Buren, Charles T.
    Kahan, Barry D.
    XENOTRANSPLANTATION, 2007, 14 (05) : 380 - 380
  • [44] Incidence of Delayed Graft Function (DGF) in a Sirolimus (SRL)-Based Versus Cyclosporine (CsA)-Based Regimen in De Novo Renal Allograft Recipients.
    Flechner, Stuart M.
    Gurkan, Alihan
    Tai, Sandi See
    Schulman, Seth L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 278 - 278
  • [45] Pharmacokinetic and pharmacodynamic correlations of cyclosporine (CsA) and rapamycin (RAPA) in 120 patients treated for at least 2 years at a single center.
    Kahan, BD
    Napoli, KL
    Mosheim, M
    Urbauer, D
    Podbielski, J
    Katz, S
    Van Buren, CT
    TRANSPLANTATION, 1999, 67 (07) : S203 - S203
  • [46] PREGNANCY OUTCOMES IN CYCLOSPORINE (CSA) TREATED FEMALE KIDNEY-TRANSPLANT RECIPIENTS WITH LONG INTERVALS FROM TRANSPLANTATION TO CONCEPTION
    GAUGHAN, WJ
    RADOMSKI, JS
    MORITZ, MJ
    ARMENTI, VT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1085 - 1085
  • [47] BETTER ALTERNATIVE IMMUNOSUPPRESSIVE PATHWAYS IN KIDNEY-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE
    TOLEDOPEREYRA, LH
    BASKIN, S
    MCNICHOL, L
    WHITTEN, J
    MITTAL, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 6 (06) : A21 - A21
  • [48] Pharmacokinetics, safety and efficacy of mycophenolate mofetil in combination with sirolimus vs cyclosporine in renal transplant patients.
    Pescovitz, M
    Vincenti, F
    Hart, M
    Melton, L
    Whelchel, J
    Mulgaonkar, S
    McKay, D
    Leung, M
    Calleja, E
    Ghahramani, P
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 251 - 251
  • [49] THE RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE
    BANFI, G
    COLTURI, C
    MONTAGNINO, G
    PONTICELLI, C
    TRANSPLANTATION, 1990, 50 (04) : 594 - 596
  • [50] Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus
    Kamar, N
    Allard, J
    Ribes, D
    Durand, D
    Ader, JL
    Rostaing, L
    CLINICAL NEPHROLOGY, 2005, 63 (02) : 80 - 86
12345